Impact of systematic lymphadenectomy at the time of interval debulking surgery on the survival of patients with advanced-stage epithelial ovarian carcinoma following neoadjuvant chemotherapy

被引：0
|
作者：
Nasioudis, Dimitrios [1 ]
Mastroyannis, Spyridon [1 ]
Latif, Nawar [1 ]
Haggerty, Ashley [1 ]
Cory, Lori [1 ]
Giuntoli, Robert [1 ]
Kim, Sarah [1 ]
Morgan, Mark [1 ]
Ko, Emily [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
344
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [21] Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
    Khalil, Kheyal Azam
    Habib, Maria
    Saeed, Afshan
    Syed, Aamir Ali
    Anwer, Abdul Wahid
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A284 - A285
  • [22] Impact of delay in interval debulking surgery after neoadjuvant chemotherapy on survival in ovarian cancer
    Khalil, Kheyal Azam
    Habib, Maria
    Usmani, Afshan Saeed
    Shah, Muhammad Ansab
    Anwer, Abdul Wahid
    Syed, Aamir Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2025, 75 (04) : 583 - 586
  • [23] Sarcopenia is a predictor of chemotherapy response score at the time of interval debulking surgery in advanced epithelial ovarian carcinoma
    Morton, Molly
    Wood, Nicole
    Alhilli, Mariam
    Kollikonda, Swapna
    Yao, Meng
    Barnard, Hannah
    Shah, Shetal
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S271 - S271
  • [24] Ascites volume at the time of primary debulking and overall survival of patients with advanced-stage epithelial ovarian cancer
    Nasioudis, Dimitrios
    Byrne, Maureen
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S91 - S91
  • [25] Assessment of peritoneal cytology in advanced-stage ovarian cancer patients at interval debulking surgery
    Kato, K.
    Omatsu, K.
    Nomura, H.
    Matoda, M.
    Matsuura, M.
    Katsuda, T.
    Okamoto, S.
    Kondo, E.
    Kanao, H.
    Utsugi, K.
    Sugiyama, Y.
    Takeshima, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 : 741 - 741
  • [26] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
    Chung, Young Shin
    Kim, Yun-Ji
    Lee, Inha
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    PLOS ONE, 2017, 12 (09):
  • [27] Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?
    Al Mutairi, Nashmia
    Le, Tien
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2019, 41 (02) : 185 - 190
  • [28] Survival impact of neoadjuvant and adjuvant chemotherapy cycles stratified by interval debulking surgical approach in advanced epithelial ovarian cancer
    Zhang, Y.
    Grant, M. S.
    Paraghamian, S. E.
    Clark, L. H.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 153 - 154
  • [29] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [30] Impact of facility-volume on achieving a textbook oncologic outcome following primary debulking surgery for advanced-stage epithelial ovarian carcinoma
    Nasioudis, Dimitrios
    Mastroyannis, Spyridon
    Ko, Emily
    Haggerty, Ashley
    Cory, Lori
    Giuntoli, Robert
    Kim, Sarah
    Morgan, Mark
    Latif, Nawar
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S178 - S178
12345